Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Becker

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Applied and Environmental Microbiology|January 1, 1983
Isolation of Vibrio cholerae serotype Ogawa from a Florida estuaryM L Motes, S R Zywno, A DePaola, et al.
Clinical Pharmacology and Therapeutics|April 1, 1984
University and pharmaceutical industry cooperation: the need to plan for the futureA J Atkinson, R E Becker, P M Galletti, et al.
Brain Research Bulletin|August 1, 1983
Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvementM M Singh, R E Becker, R K Pitman, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1994
Oral administration of heptylphysostigmine in healthy volunteers: a preliminary studyL K Unni, J Radcliffe, G Latham, et al.
Endocrinology|May 1, 1990
Regulation of low molecular weight insulin-like growth factor binding proteins in experimental diabetes mellitusT G Unterman, K Patel, V K Mahathre, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 22, 1999
Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's diseaseP L Moriearty, P Seubert, D Galasko, et al.
Alzheimer Disease and Associated Disorders|April 16, 1998
Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month studyR E Becker, J A Colliver, S J Markwell, et al.
Alzheimer Disease and Associated Disorders|January 1, 1996
Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer diseaseR E Becker, J A Colliver, S J Markwell, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1990
Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2G T Ooi, C C Orlowski, A L Brown, et al.
American Journal of Hematology|August 1, 1991
Stability of peripheral hematological parameters after chronic acetylcholinesterase inhibition in manP L Moriearty, C L Womack, B W Dick, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Applied and Environmental Microbiology|January 1, 1983
Isolation of Vibrio cholerae serotype Ogawa from a Florida estuaryM L Motes, S R Zywno, A DePaola, et al.
Clinical Pharmacology and Therapeutics|April 1, 1984
University and pharmaceutical industry cooperation: the need to plan for the futureA J Atkinson, R E Becker, P M Galletti, et al.
Brain Research Bulletin|August 1, 1983
Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvementM M Singh, R E Becker, R K Pitman, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1994
Oral administration of heptylphysostigmine in healthy volunteers: a preliminary studyL K Unni, J Radcliffe, G Latham, et al.
Endocrinology|May 1, 1990
Regulation of low molecular weight insulin-like growth factor binding proteins in experimental diabetes mellitusT G Unterman, K Patel, V K Mahathre, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 22, 1999
Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's diseaseP L Moriearty, P Seubert, D Galasko, et al.
Alzheimer Disease and Associated Disorders|April 16, 1998
Effects of metrifonate on cognitive decline in Alzheimer disease: a double-blind, placebo-controlled, 6-month studyR E Becker, J A Colliver, S J Markwell, et al.
Alzheimer Disease and Associated Disorders|January 1, 1996
Double-blind, placebo-controlled study of metrifonate, an acetylcholinesterase inhibitor, for Alzheimer diseaseR E Becker, J A Colliver, S J Markwell, et al.
Molecular Endocrinology (Baltimore, Md.)|February 1, 1990
Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2G T Ooi, C C Orlowski, A L Brown, et al.
American Journal of Hematology|August 1, 1991
Stability of peripheral hematological parameters after chronic acetylcholinesterase inhibition in manP L Moriearty, C L Womack, B W Dick, et al.
Pageof 8